These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 6110093)

  • 41. Gastric secretory response to graded doses of pentagastrin alone or in combination with carbacholine in unoperated duodenal ulcer patients.
    Roland M
    Scand J Gastroenterol; 1975; 10(6):603-8. PubMed ID: 1101365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pentagastrin dose-response in peptic ulcer disease.
    Petersen H; Myren J
    Scand J Gastroenterol; 1975; 10(7):705-14. PubMed ID: 1103272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A secretory and histological study of the stomach before and after truncal vagotomy and pyloroplasty in duodenal ulcer patients.
    Roland M
    Scand J Gastroenterol; 1976; 11(1):65-71. PubMed ID: 766154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction of pentagastrin stimulated acid output: a suitable method to predict efficacy of an irreversible proton pump inhibitor in peptic ulcer disease?
    Bliesath H; Simon B; Hartmann M; Müller P; Schneider A; Lühmann R; Wurst W
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):439. PubMed ID: 1337063
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibition of pentagastrin-stimulated gastric secretion by pyridyl-2-tetrahydrothiophene derivative (RP 40749).
    Minaire Y; Forichon J; Woehrle R
    Lancet; 1982 May; 1(8282):1179-80. PubMed ID: 6122950
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of somatostatin on pentagastrin-stimulated gastric secretion and on plasma gastrin in man.
    Vatn MH; Schrumpf E; Hanssen KF; Myren J
    Scand J Gastroenterol; 1977; 12(7):833-9. PubMed ID: 339322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ranitidine inhibition of gastric secretion stimulated by pentagastrin. Results in 30 cases of duodenal ulcer].
    Toulet J; Pagniez R; Viteau JM; Rousselet J; Bosc F; Vienne JL
    Ann Gastroenterol Hepatol (Paris); 1986; 22(1):9-14. PubMed ID: 3083759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pepsin 1 secretion in chronic peptic ulceration.
    Walker V; Taylor WH
    Gut; 1980 Sep; 21(9):766-71. PubMed ID: 6776016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intestinal phase of gastric secretion in patients with duodenal ulcer.
    Konturek SJ; Kwiecien N; Obtułowicz W; Sito E; Oleksy J
    Gut; 1978 Apr; 19(4):321-6. PubMed ID: 25829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endogenous prostaglandins and gastric secretion in the cat.
    Baker R; Jaffe BM; Reed JD; Shaw B; Venables CW
    J Physiol; 1978 May; 278():451-60. PubMed ID: 353256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of glucagon on meal-induced gastric secretion in man.
    Konturek SJ; Biernat J; Kwiecień N; Oleksy J
    Gastroenterology; 1975 Mar; 68(3):448-54. PubMed ID: 1089577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of esaprazole activity on basal gastric secretion and on pentagastrin-stimulated secretion in healthy volunteers.
    Erembourg L; Reggiani P; Tosi GP; Ferla G; Beinat L
    Int J Clin Pharmacol Res; 1987; 7(2):95-100. PubMed ID: 3583500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endogenous prostaglandins and stimulated gastric secretion in the cat: the effect of various secretory inhibitors.
    Baker R; Jaffe BM; Reed JD; Shaw B; Venables CW
    J Physiol; 1979 Jun; 291():1-9. PubMed ID: 383948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of somatostatin on meal-induced gastric secretion in duodenal ulcer patients.
    Konturek SJ; Swierczek J; Kwiecień N; Mikoś E; Oleksy J; Wierzbicki Z
    Am J Dig Dis; 1977 Nov; 22(11):981-8. PubMed ID: 335884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heidenhain pouch distension as a stimulus for acid and pepsin secretion.
    Magee DF; Hu CY
    Ann Surg; 1975 Aug; 182(2):121-3. PubMed ID: 1108812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastric pepsin and acid secretion following various operations for gastric and duodenal ulcer.
    Sekine T; Kameyama J; Sato T
    Tohoku J Exp Med; 1980 Jan; 130(1):79-85. PubMed ID: 6768166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition by somatostatin (growth-hormone release-inhibiting hormone, GH-RIH) of gastric acid and pepsin and G-cell release of gastrin.
    Barros D'sa AA; Bloom SR; Baron JH
    Gut; 1978 Apr; 19(4):315-20. PubMed ID: 348581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of fundic vagotomy and cholinergic replacement on pentagastrin dose responsive gastric acid and pepsin secretion in man.
    Hirschowitz BI; Helman CA
    Gut; 1982 Aug; 23(8):675-82. PubMed ID: 6807759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of pirenzepine on basal gastric acid and pepsin secretion and on secretion stimulated with graded doses of pentagastrin in duodenal ulcer patients.
    Meneghelli UG; Troncon LE
    Braz J Med Biol Res; 1988; 21(4):781-9. PubMed ID: 3149202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-activity relationships of eighteen somatostatin analogues on gastric secretion.
    Brown MP; Coy DH; Gomez-Pan A; Hirst BH; Hunter M; Meyers C; Reed JD; Schally AV; Shaw B
    J Physiol; 1978 Apr; 277():1-14. PubMed ID: 349135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.